{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T05:55:11Z","timestamp":1785218111052,"version":"3.55.0"},"reference-count":77,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.m2022.0410","type":"journal-article","created":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T13:43:51Z","timestamp":1677591831000},"source":"Crossref","is-referenced-by-count":4,"title":["Neurosurgical interventions for cerebral metastases of solid tumors"],"prefix":"10.3238","author":[{"given":"Niklas","family":"Thon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Karschnia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louisa von","family":"Baumgarten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Niyazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim P.","family":"Steinbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg-Christian","family":"Tonn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2023,3,10]]},"reference":[{"key":"10.3238\/arztebl.m2022.0410_ref1","doi-asserted-by":"crossref","unstructured":"Cagney DN, Martin AM, Catalano PJ, et al.: Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study. Neuro Oncol 2017; 19: 1511–21.","DOI":"10.1093\/neuonc\/nox077"},{"key":"10.3238\/arztebl.m2022.0410_ref2","doi-asserted-by":"crossref","unstructured":"Lamba N, Wen PY, Aizer AA: Epidemiology of brain metastases and leptomeningeal disease. Neuro Oncol 2021; 23: 1447–56.","DOI":"10.1093\/neuonc\/noab101"},{"key":"10.3238\/arztebl.m2022.0410_ref3","doi-asserted-by":"crossref","unstructured":"Steindl A, Brunner TJ, Heimbach K, et al.: Changing characteristics, treatment approaches and survival of patients with brain metastasis: data from six thousand and thirty-one individuals over an observation period of 30 years. Eur J Cancer 2022; 162: 170–81.","DOI":"10.1016\/j.ejca.2021.12.005"},{"key":"10.3238\/arztebl.m2022.0410_ref4","doi-asserted-by":"crossref","unstructured":"Le Rhun E, Guckenberger M, Smits M, et al.: EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours. Ann Oncol 2021; 32: 1332–47.","DOI":"10.1016\/j.annonc.2021.07.016"},{"key":"10.3238\/arztebl.m2022.0410_ref5","doi-asserted-by":"crossref","unstructured":"Vogelbaum MA, Brown PD, Messersmith H, et al.: Treatment for brain metastases: ASCO-SNO-ASTRO guideline. J Clin Oncol 2022; 40: 492–516.","DOI":"10.1200\/JCO.21.02314"},{"key":"10.3238\/arztebl.m2022.0410_ref6","doi-asserted-by":"crossref","unstructured":"Karschnia P, Le Rhun E, Vogelbaum MA, et al.: The evolving role of neurosurgery for central nervous system metastases in the era of personalized cancer therapy. Eur J Cancer 2021; 156: 93–108.","DOI":"10.1016\/j.ejca.2021.07.032"},{"key":"10.3238\/arztebl.m2022.0410_ref7","doi-asserted-by":"crossref","unstructured":"L\u00f3pez V\u00e1zquez M, Du W, Kanaya N, Kitamura Y, Shah K: Next-generation immunotherapies for brain metastatic cancers. Trends Cancer 2021; 7: 809–22.","DOI":"10.1016\/j.trecan.2021.02.003"},{"key":"10.3238\/arztebl.m2022.0410_ref8","doi-asserted-by":"crossref","unstructured":"Chukwueke UN, Brastianos PK: Sequencing brain metastases and opportunities for targeted therapies. Pharmacogenomics 2017; 18: 585–94.","DOI":"10.2217\/pgs-2016-0170"},{"key":"10.3238\/arztebl.m2022.0410_ref9","doi-asserted-by":"crossref","unstructured":"Lee D, Riestenberg RA, Haskell-Mendoza A, Bloch O: Brain metastasis recurrence versus radiation necrosis: evaluation and treatment. Neurosurg Clin N Am 2020; 31: 575–87.","DOI":"10.1016\/j.nec.2020.06.007"},{"key":"10.3238\/arztebl.m2022.0410_ref10","doi-asserted-by":"crossref","unstructured":"Le Rhun E, Wolpert F, Fialek M, et al.: Response assessment and outcome of combining immunotherapy and radiosurgery for brain metastasis from malignant melanoma. ESMO Open 2020; 5: e000763.","DOI":"10.1136\/esmoopen-2020-000763"},{"key":"10.3238\/arztebl.m2022.0410_ref11","doi-asserted-by":"crossref","unstructured":"Katzendobler S, Do A, Weller J, et al.: Diagnostic yield and complication rate of stereotactic biopsies in precision medicine of gliomas. Front Neurol 2022; 13: 822362.","DOI":"10.3389\/fneur.2022.822362"},{"key":"10.3238\/arztebl.m2022.0410_ref12","doi-asserted-by":"crossref","unstructured":"Tan AC, Bagley SJ, Wen PY, et al.: Systematic review of combinations of targeted or immunotherapy in advanced solid tumors. J Immunother Cancer 2021; 9: e002459.","DOI":"10.1136\/jitc-2021-002459"},{"key":"10.3238\/arztebl.m2022.0410_ref13","unstructured":"Brastianos PK, Carter SL, Santagata S, et al.: Genomic characterization of brain metastases reveals branched evolution and potential therapeutic targets. Cancer Discov 2015; 5: 1164–77."},{"key":"10.3238\/arztebl.m2022.0410_ref14","unstructured":"Sperduto PW, Mesko S, Li J, et al.: Survival in patients with brain metastases: summary report on the updated diagnosis-specific graded prognostic assessment and definition of the eligibility quotient. J Clin Oncol 2020; 38: 3773–84."},{"key":"10.3238\/arztebl.m2022.0410_ref15","doi-asserted-by":"crossref","unstructured":"Steindl A, Yadavalli S, Gruber KA, et al.: Neurological symptom burden impacts survival prognosis in patients with newly diagnosed non-small cell lung cancer brain metastases. Cancer 2020; 126: 4341–52.","DOI":"10.1002\/cncr.33085"},{"key":"10.3238\/arztebl.m2022.0410_ref16","doi-asserted-by":"crossref","unstructured":"Lamba N, Kearney RB, Catalano PJ, et al.: Population-based estimates of survival among elderly patients with brain metastases. Neuro Oncol 2021; 23: 661–76.","DOI":"10.1093\/neuonc\/noaa233"},{"key":"10.3238\/arztebl.m2022.0410_ref17","doi-asserted-by":"crossref","unstructured":"Sch\u00f6del P, J\u00fcnger ST, Wittersheim M, et al.: Surgical resection of symptomatic brain metastases improves the clinical status and facilitates further treatment. Cancer Med 2020; 9: 7503–10.","DOI":"10.1002\/cam4.3402"},{"key":"10.3238\/arztebl.m2022.0410_ref18","doi-asserted-by":"crossref","unstructured":"Gupta S, Dawood H, Giantini Larsen A, et al.: Surgical and peri-operative considerations for brain metastases. Front Oncol 2021; 11: 662943.","DOI":"10.3389\/fonc.2021.662943"},{"key":"10.3238\/arztebl.m2022.0410_ref19","doi-asserted-by":"crossref","unstructured":"Berghoff AS, Rajky O, Winkler F, et al.: Invasion patterns in brain metastases of solid cancers. Neuro Oncol 2013; 15: 1664–72.","DOI":"10.1093\/neuonc\/not112"},{"key":"10.3238\/arztebl.m2022.0410_ref20","doi-asserted-by":"crossref","unstructured":"Kamp MA, Rapp M, Slotty PJ, et al.: Incidence of local in-brain progression after supramarginal resection of cerebral metastases. Acta Neurochir (Wien) 2015; 157: 905–10; discussion 10–1.","DOI":"10.1007\/s00701-015-2405-9"},{"key":"10.3238\/arztebl.m2022.0410_ref21","doi-asserted-by":"crossref","unstructured":"Patel AJ, Suki D, Hatiboglu MA, Rao VY, Fox BD, Sawaya R: Impact of surgical methodology on the complication rate and functional outcome of patients with a single brain metastasis. J Neurosurg 2015; 122: 1132–43.","DOI":"10.3171\/2014.9.JNS13939"},{"key":"10.3238\/arztebl.m2022.0410_ref22","doi-asserted-by":"crossref","unstructured":"Tewarie IA, Jessurun CAC, Hulsbergen AFC, Smith TR, Mekary RA, Broekman MLD: Leptomeningeal disease in neurosurgical brain metastases patients: a systematic review and meta-analysis. Neurooncol Adv 2021; 3: vdab162.","DOI":"10.1093\/noajnl\/vdab162"},{"key":"10.3238\/arztebl.m2022.0410_ref23","doi-asserted-by":"crossref","unstructured":"Nguyen TK, Sahgal A, Detsky J, et al.: Predictors of leptomeningeal disease following hypofractionated stereotactic radiotherapy for intact and resected brain metastases. Neuro Oncol 2020; 22: 84–93.","DOI":"10.1093\/neuonc\/noz144"},{"key":"10.3238\/arztebl.m2022.0410_ref24","doi-asserted-by":"crossref","unstructured":"Prabhu RS, Turner BE, Asher AL, et al.: A multi-institutional analysis of presentation and outcomes for leptomeningeal disease recurrence after surgical resection and radiosurgery for brain metastases. Neuro Oncol 2019; 21: 1049–59.","DOI":"10.1093\/neuonc\/noz049"},{"key":"10.3238\/arztebl.m2022.0410_ref25","doi-asserted-by":"crossref","unstructured":"Kiesel B, Prihoda R, Borkovec M, et al.: Postoperative magnetic resonance imaging after surgery of brain metastases: analysis of extent of resection and potential risk factors for incomplete resection. World Neurosurg 2020; 143: e365-e73.","DOI":"10.1016\/j.wneu.2020.07.150"},{"key":"10.3238\/arztebl.m2022.0410_ref26","doi-asserted-by":"crossref","unstructured":"Sanmillan JL, Fern\u00e1ndez-Coello A, Fern\u00e1ndez-Conejero I, Plans G, Gabarr\u00f3s A: Functional approach using intraoperative brain mapping and neurophysiological monitoring for the surgical treatment of brain metastases in the central region. J Neurosurg 2017; 126: 698–707.","DOI":"10.3171\/2016.2.JNS152855"},{"key":"10.3238\/arztebl.m2022.0410_ref27","doi-asserted-by":"crossref","unstructured":"Muacevic A, Wowra B, Siefert A, Tonn JC, Steiger HJ, Kreth FW: Microsurgery plus whole brain irradiation versus Gamma Knife surgery alone for treatment of single metastases to the brain: a randomized controlled multicentre phase III trial. J Neurooncol 2008; 87: 299–307.","DOI":"10.1007\/s11060-007-9510-4"},{"key":"10.3238\/arztebl.m2022.0410_ref28","doi-asserted-by":"crossref","unstructured":"Mahajan A, Ahmed S, McAleer MF, et al.: Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial. Lancet Oncol 2017; 18: 1040–8.","DOI":"10.1016\/S1470-2045(17)30414-X"},{"key":"10.3238\/arztebl.m2022.0410_ref29","doi-asserted-by":"crossref","unstructured":"Ene CI, Ferguson SD: Surgical management of brain metastasis: challenges and nuances. Front Oncol 2022; 12: 847110.","DOI":"10.3389\/fonc.2022.847110"},{"key":"10.3238\/arztebl.m2022.0410_ref30","doi-asserted-by":"crossref","unstructured":"Alvarez-Breckenridge C, Giobbie-Hurder A, Gill CM, et al.: Upfront surgical resection of melanoma brain metastases provides a bridge toward immunotherapy-mediated systemic control. Oncologist 2019; 24: 671–9.","DOI":"10.1634\/theoncologist.2018-0306"},{"key":"10.3238\/arztebl.m2022.0410_ref31","doi-asserted-by":"crossref","unstructured":"Petrelli F, Signorelli D, Ghidini M, et al.: Association of steroids use with survival in patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis. Cancers (Basel) 2020; 12: 546.","DOI":"10.3390\/cancers12030546"},{"key":"10.3238\/arztebl.m2022.0410_ref32","doi-asserted-by":"crossref","unstructured":"Bodensohn R, Kaempfel AL, Fleischmann DF, et al.: Simultaneous stereotactic radiosurgery of multiple brain metastases using single-isocenter dynamic conformal arc therapy: a prospective monocentric registry trial. Strahlenther Onkol 2021; 197: 601–13.","DOI":"10.1007\/s00066-021-01773-6"},{"key":"10.3238\/arztebl.m2022.0410_ref33","doi-asserted-by":"crossref","unstructured":"Mitsuya K, Nakasu Y, Hayashi N, et al.: Retrospective analysis of salvage surgery for local progression of brain metastasis previously treated with stereotactic irradiation: diagnostic contribution, functional outcome, and prognostic factors. BMC Cancer 2020; 20: 331.","DOI":"10.1186\/s12885-020-06800-w"},{"key":"10.3238\/arztebl.m2022.0410_ref34","doi-asserted-by":"crossref","unstructured":"He\u00dfler N, J\u00fcnger ST, Meissner AK, Kocher M, Goldbrunner R, Grau S: Recurrent brain metastases: the role of resection of in a comprehensive multidisciplinary treatment setting. BMC Cancer 2022; 22: 275.","DOI":"10.1186\/s12885-022-09317-6"},{"key":"10.3238\/arztebl.m2022.0410_ref35","doi-asserted-by":"crossref","unstructured":"Galldiks N, Langen KJ, Albert NL, et al.: PET imaging in patients with brain metastasis-report of the RANO\/PET group. Neuro Oncol 2019; 21: 585–95.","DOI":"10.1093\/neuonc\/noz003"},{"key":"10.3238\/arztebl.m2022.0410_ref36","doi-asserted-by":"crossref","unstructured":"Beauchesne P: Intrathecal chemotherapy for treatment of leptomeningeal dissemination of metastatic tumours. Lancet Oncol 2010; 11: 871–9.","DOI":"10.1016\/S1470-2045(10)70034-6"},{"key":"10.3238\/arztebl.m2022.0410_ref37","doi-asserted-by":"crossref","unstructured":"Montes de Oca Delgado M, Cacho D\u00edaz B, Santos Zambrano J, et al.: The comparative treatment of intraventricular chemotherapy by ommaya reservoir vs. lumbar puncture in patients with leptomeningeal carcinomatosis. Front Oncol 2018; 8: 509.","DOI":"10.3389\/fonc.2018.00509"},{"key":"10.3238\/arztebl.m2022.0410_ref38","doi-asserted-by":"crossref","unstructured":"Omuro AM, Lallana EC, Bilsky MH, DeAngelis LM: Ventriculoperitoneal shunt in patients with leptomeningeal metastasis. Neurology 2005; 64: 1625–7.","DOI":"10.1212\/01.WNL.0000160396.69050.DC"},{"key":"10.3238\/arztebl.m2022.0410_ref39","doi-asserted-by":"crossref","unstructured":"Nigim F, Critchlow JF, Kasper EM: Role of ventriculoperitoneal shunting in patients with neoplasms of the central nervous system: an analysis of 59 cases. Mol Clin Oncol 2015; 3: 1381–6.","DOI":"10.3892\/mco.2015.627"},{"key":"10.3238\/arztebl.m2022.0410_ref40","doi-asserted-by":"crossref","unstructured":"Vogelbaum MA, Krivosheya D, Borghei-Razavi H, et al.: Phase 0 and window of opportunity clinical trial design in neuro-oncology: A RANO Review. Neuro Oncol 2020; 22: 1568–79.","DOI":"10.1093\/neuonc\/noaa149"},{"key":"10.3238\/arztebl.m2022.0410_ref41","doi-asserted-by":"crossref","unstructured":"Ostrom QT, Wright CH, Barnholtz-Sloan JS: Brain metastases: epidemiology. Handb Clin Neurol 2018; 149: 27–42.","DOI":"10.1016\/B978-0-12-811161-1.00002-5"},{"key":"10.3238\/arztebl.m2022.0410_ref42","doi-asserted-by":"crossref","unstructured":"Berghoff AS, Schur S, F\u00fcreder LM, et al.: Descriptive statistical analysis of a real life cohort of 2419 patients with brain metastases of solid cancers. ESMO Open 2016; 1: e000024.","DOI":"10.1136\/esmoopen-2015-000024"},{"key":"10.3238\/arztebl.m2022.0410_ref43","doi-asserted-by":"crossref","unstructured":"Kromer C, Xu J, Ostrom QT, et al.: Estimating the annual frequency of synchronous brain metastasis in the United States 2010–2013: a population-based study. J Neurooncol 2017; 134: 55–64.","DOI":"10.1007\/s11060-017-2516-7"},{"key":"10.3238\/arztebl.m2022.0410_ref44","doi-asserted-by":"crossref","unstructured":"Kaul D, Berghoff AS, Grosu AL, Lucas CW, Guckenberger M: Focal radiotherapy of brain metastases in combination with immunotherapy and targeted drug therapy. Dtsch Arztebl Int 2021; 118: 759–66.","DOI":"10.3238\/arztebl.m2021.0332"},{"key":"10.3238\/arztebl.m2022.0410_ref45","doi-asserted-by":"crossref","unstructured":"Soffietti R, Abacioglu U, Baumert B, et al.: Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO). Neuro Oncol 2017; 19: 162–74.","DOI":"10.1093\/neuonc\/now241"},{"key":"10.3238\/arztebl.m2022.0410_ref46","unstructured":"Brastianos PK, Carter SL, Santagata S, et al.: Genomic characterization of brain metastases reveals branched evolution and potential therapeutic targets. Cancer Discov 2015; 5: 1164–77."},{"key":"10.3238\/arztebl.m2022.0410_ref47","doi-asserted-by":"crossref","unstructured":"Okada H, Weller M, Huang R, et al.: Immunotherapy response assessment in neuro-oncology: a report of the RANO working group. Lancet Oncol 2015; 16: e534-e42.","DOI":"10.1016\/S1470-2045(15)00088-1"},{"key":"10.3238\/arztebl.m2022.0410_ref48","doi-asserted-by":"crossref","unstructured":"Riche M, Amelot A, Peyre M, Capelle L, Carpentier A, Mathon B: Complications after frame-based stereotactic brain biopsy: a systematic review. Neurosurg Rev 2021; 44: 301–7.","DOI":"10.1007\/s10143-019-01234-w"},{"key":"10.3238\/arztebl.m2022.0410_ref49","doi-asserted-by":"crossref","unstructured":"Karlsson B, Ericson K, Kihlstr\u00f6m L, Grane P: Tumor seeding following stereotactic biopsy of brain metastases. Report of two cases. J Neurosurg 1997; 87: 327–30.","DOI":"10.3171\/jns.1997.87.2.0327"},{"key":"10.3238\/arztebl.m2022.0410_ref50","doi-asserted-by":"crossref","unstructured":"Pinggera D, Kvitsaridtze I, Stockhammer G, et al.: Serious tumor seeding after brainstem biopsy and its treatment-a case report and review of the literature. Acta Neurochir (Wien) 2017; 159: 751–4.","DOI":"10.1007\/s00701-017-3102-7"},{"key":"10.3238\/arztebl.m2022.0410_ref51","doi-asserted-by":"crossref","unstructured":"Berghoff AS, Bartsch R, W\u00f6hrer A, et al.: Predictive molecular markers in metastases to the central nervous system: recent advances and future avenues. Acta Neuropathol 2014; 128: 879–91.","DOI":"10.1007\/s00401-014-1350-7"},{"key":"10.3238\/arztebl.m2022.0410_ref52","doi-asserted-by":"crossref","unstructured":"Duchnowska R, Dziadziuszko R, Trojanowski T, et al.: Conversion of epidermal growth factor receptor 2 and hormone receptor expression in breast cancer metastases to the brain. Breast Cancer Res 2012; 14: R119.","DOI":"10.1186\/bcr3244"},{"key":"10.3238\/arztebl.m2022.0410_ref53","doi-asserted-by":"crossref","unstructured":"Riveiro-Falkenbach E, Villanueva CA, Garrido MC, et al.: Intra- and inter-tumoral homogeneity of BRAF(V600E) mutations in melanoma tumors. J Invest Dermatol 2015; 135: 3078–85.","DOI":"10.1038\/jid.2015.229"},{"key":"10.3238\/arztebl.m2022.0410_ref54","doi-asserted-by":"crossref","unstructured":"Clark AJ, Butowski NA, Chang SM, et al.: Impact of bevacizumab chemotherapy on craniotomy wound healing. J Neurosurg 2011; 114: 1609–16.","DOI":"10.3171\/2010.10.JNS101042"},{"key":"10.3238\/arztebl.m2022.0410_ref55","doi-asserted-by":"crossref","unstructured":"Schipmann S, Akalin E, Doods J, Ewelt C, Stummer W, Suero Molina E: When the infection hits the wound: matched case-control study in a neurosurgical patient collective including systematic literature review and risk factors analysis. World Neurosurg 2016; 95: 178–89.","DOI":"10.1016\/j.wneu.2016.07.093"},{"key":"10.3238\/arztebl.m2022.0410_ref56","doi-asserted-by":"crossref","unstructured":"Yoo H, Kim YZ, Nam BH, et al.: Reduced local recurrence of a single brain metastasis through microscopic total resection. J Neurosurg 2009; 110: 730–6.","DOI":"10.3171\/2008.8.JNS08448"},{"key":"10.3238\/arztebl.m2022.0410_ref57","doi-asserted-by":"crossref","unstructured":"Lee CH, Kim DG, Kim JW, et al.: The role of surgical resection in the management of brain metastasis: a 17-year longitudinal study. Acta Neurochir (Wien) 2013; 155: 389–97.","DOI":"10.1007\/s00701-013-1619-y"},{"key":"10.3238\/arztebl.m2022.0410_ref58","doi-asserted-by":"crossref","unstructured":"Proescholdt M, J\u00fcnger ST, Sch\u00f6del P, et al.: Brain metastases in elderly patients—the role of surgery in the context of systemic treatment. Brain Sci 2021; 11: 123.","DOI":"10.3390\/brainsci11010123"},{"key":"10.3238\/arztebl.m2022.0410_ref59","doi-asserted-by":"crossref","unstructured":"Shaw E, Scott C, Souhami L, et al.: Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90–05. Int J Radiat Oncol Biol Phys 2000; 47: 291–8.","DOI":"10.1016\/S0360-3016(99)00507-6"},{"key":"10.3238\/arztebl.m2022.0410_ref60","doi-asserted-by":"crossref","unstructured":"Minniti G, Clarke E, Lanzetta G, et al.: Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis. Radiat Oncol 2011; 6: 48.","DOI":"10.1186\/1748-717X-6-48"},{"key":"10.3238\/arztebl.m2022.0410_ref61","doi-asserted-by":"crossref","unstructured":"Lehrer EJ, Peterson JL, Zaorsky NG, et al.: Single versus multifraction stereotactic radiosurgery for large brain metastases: an international meta-analysis of 24 trials. Int J Radiat Oncol Biol Phys 2019; 103: 618–30.","DOI":"10.1016\/j.ijrobp.2018.10.038"},{"key":"10.3238\/arztebl.m2022.0410_ref62","unstructured":"Lee SR, Oh JY, Kim SH: Gamma knife radiosurgery for cystic brain metastases. Br J Neurosurg 2016; 30: 43–8."},{"key":"10.3238\/arztebl.m2022.0410_ref63","doi-asserted-by":"crossref","unstructured":"Wang H, Liu X, Jiang X, et al.: Cystic brain metastases had slower speed of tumor shrinkage but similar prognosis compared with solid tumors that underwent radiosurgery treatment. Cancer Manag Res 2019; 11: 1753–63.","DOI":"10.2147\/CMAR.S188674"},{"key":"10.3238\/arztebl.m2022.0410_ref64","doi-asserted-by":"crossref","unstructured":"Schackert G, Schmiedel K, Lindner C, Leimert M, Kirsch M: Surgery of recurrent brain metastases: retrospective analysis of 67 patients. Acta Neurochir (Wien) 2013; 155: 1823–32.","DOI":"10.1007\/s00701-013-1821-y"},{"key":"10.3238\/arztebl.m2022.0410_ref65","doi-asserted-by":"crossref","unstructured":"Galldiks N, Abdulla DSY, Scheffler M, et al.: Treatment monitoring of immunotherapy and targeted therapy using (18)F-FET PET in patients with melanoma and lung cancer brain metastases: initial experiences. J Nucl Med 2021; 62: 464–70.","DOI":"10.2967\/jnumed.120.248278"},{"key":"10.3238\/arztebl.m2022.0410_ref66","doi-asserted-by":"crossref","unstructured":"Soler DC, Kerstetter-Fogle A, Elder T, et al.: A liquid biopsy to assess brain tumor recurrence: presence of circulating Mo-MDSC and CD14+ VNN2+ myeloid cells as biomarkers that distinguish brain metastasis from radiation necrosis following stereotactic radiosurgery. Neurosurgery 2020; 88: E67– e72.","DOI":"10.1093\/neuros\/nyaa334"},{"key":"10.3238\/arztebl.m2022.0410_ref67","doi-asserted-by":"crossref","unstructured":"Chamberlain MC, Kormanik PA: Prognostic significance of 111indium-DTPA CSF flow studies in leptomeningeal metastases. Neurology 1996; 46: 1674–7.","DOI":"10.1212\/WNL.46.6.1674"},{"key":"10.3238\/arztebl.m2022.0410_ref68","doi-asserted-by":"crossref","unstructured":"Mason WP, Yeh SD, DeAngelis LM: 111Indium-diethylenetriamine pentaacetic acid cerebrospinal fluid flow studies predict distribution of intrathecally administered chemotherapy and outcome in patients with leptomeningeal metastases. Neurology 1998; 50: 438–44.","DOI":"10.1212\/WNL.50.2.438"},{"key":"10.3238\/arztebl.m2022.0410_ref69","doi-asserted-by":"crossref","unstructured":"Kim HS, Park JB, Gwak HS, Kwon JW, Shin SH, Yoo H: Clinical outcome of cerebrospinal fluid shunts in patients with leptomeningeal carcinomatosis. World J Surg Oncol 2019; 17: 59.","DOI":"10.1186\/s12957-019-1595-7"},{"key":"10.3238\/arztebl.m2022.0410_ref70","doi-asserted-by":"crossref","unstructured":"Roos DE, Smith JG, Stephens SW: Radiosurgery versus surgery, both with adjuvant whole brain radiotherapy, for solitary brain metastases: a randomised controlled trial. Clin Oncol (R Coll Radiol) 2011; 23: 646–51.","DOI":"10.1016\/j.clon.2011.04.009"},{"key":"10.3238\/arztebl.m2022.0410_ref71","doi-asserted-by":"crossref","unstructured":"Mintz AH, Kestle J, Rathbone MP, et al.: A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis. Cancer 1996; 78: 1470–6.","DOI":"10.1002\/(SICI)1097-0142(19961001)78:7<1470::AID-CNCR14>3.0.CO;2-X"},{"key":"10.3238\/arztebl.m2022.0410_ref72","doi-asserted-by":"crossref","unstructured":"Vecht CJ, Haaxma-Reiche H, Noordijk EM, et al.: Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery? Ann Neurol 1993; 33: 583–90.","DOI":"10.1002\/ana.410330605"},{"key":"10.3238\/arztebl.m2022.0410_ref73","doi-asserted-by":"crossref","unstructured":"Patchell RA, Tibbs PA, Walsh JW, et al.: A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990; 322: 494–500.","DOI":"10.1056\/NEJM199002223220802"},{"key":"10.3238\/arztebl.m2022.0410_ref74","doi-asserted-by":"crossref","unstructured":"Aftahy AK, Barz M, Lange N, et al.: The impact of postoperative tumor burden on patients with brain metastases. Front Oncol 2022; 12: 869764.","DOI":"10.3389\/fonc.2022.869764"},{"key":"10.3238\/arztebl.m2022.0410_ref75","unstructured":"Junger ST, Reinecke D, Meissner AK, Goldbrunner R, Grau S: Resection of symptomatic non-small cell lung cancer brain metastasis in the setting of multiple brain metastases. J Neurosurg 2021: 1–7."},{"key":"10.3238\/arztebl.m2022.0410_ref76","unstructured":"Paek SH, Audu PB, Sperling MR, Cho J, Andrews DW: Reevaluation of surgery for the treatment of brain metastases: review of 208 patients with single or multiple brain metastases treated at one institution with modern neurosurgical techniques. Neurosurgery 2005; 56: 1021–34; discussion—34."},{"key":"10.3238\/arztebl.m2022.0410_ref77","doi-asserted-by":"crossref","unstructured":"Bindal RK, Sawaya R, Leavens ME, Lee JJ: Surgical treatment of multiple brain metastases. J Neurosurg 1993; 79: 210–6.","DOI":"10.3171\/jns.1993.79.2.0210"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2022.0410","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T13:44:21Z","timestamp":1677591861000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2022.0410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,10]]},"references-count":77,"URL":"https:\/\/doi.org\/10.3238\/arztebl.m2022.0410","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,10]]}}}